Systemic and central nervous system neuroinflammatory signatures of neuropsychiatric symptoms and related cognitive decline in older people.
Fiche du document
28 mai 2022
- doi: 10.1186/s12974-022-02473-3
- issn: 1742-2094
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12974-022-02473-3
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/35643540
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1742-2094
Ce document est lié à :
info:eu-repo/grantAgreement/SNF/Projects/320030_141179///
Ce document est lié à :
info:eu-repo/grantAgreement/FOUNDATION_SYNAPSIS//2017-PI01///
Ce document est lié à :
info:eu-repo/grantAgreement/OTHER/////
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_8E3700B6EFDF2
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Sujets proches
Semiology (Medicine) Diseases--Symptoms Symptomatology Signs, Clinical Clinical signs Semiology Symptomology Signs and symptoms Disease symptoms Blood--Serum Blood serum Disease (Pathology) Older persons Older adults Seniors (Older people) Elderly people Old people Senior citizens Aging people Aged illnessCiter ce document
C. Clark et al., « Systemic and central nervous system neuroinflammatory signatures of neuropsychiatric symptoms and related cognitive decline in older people. », Serveur académique Lausannois, ID : 10.1186/s12974-022-02473-3
Métriques
Partage / Export
Résumé
Neuroinflammation may contribute to psychiatric symptoms in older people, in particular in the context of Alzheimer's disease (AD). We sought to identify systemic and central nervous system (CNS) inflammatory alterations associated with neuropsychiatric symptoms (NPS); and to investigate their relationships with AD pathology and clinical disease progression. We quantified a panel of 38 neuroinflammation and vascular injury markers in paired serum and cerebrospinal fluid (CSF) samples in a cohort of cognitively normal and impaired older subjects. We performed neuropsychiatric and cognitive evaluations and measured CSF biomarkers of AD pathology. Multivariate analysis determined serum and CSF neuroinflammatory alterations associated with NPS, considering cognitive status, AD pathology, and cognitive decline at follow-up visits. NPS were associated with distinct inflammatory profiles in serum, involving eotaxin-3, interleukin (IL)-6 and C-reactive protein (CRP); and in CSF, including soluble intracellular cell adhesion molecule-1 (sICAM-1), IL-8, 10-kDa interferon-γ-induced protein, and CRP. AD pathology interacted with CSF sICAM-1 in association with NPS. Presenting NPS was associated with subsequent cognitive decline which was mediated by CSF sICAM-1. Distinct systemic and CNS inflammatory processes are involved in the pathophysiology of NPS in older people. Neuroinflammation may explain the link between NPS and more rapid clinical disease progression.